ExodusPoint Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-332,207
| Closed | -$2.71M | – | 1540 |
|
|
2025
Q1 | $2.71M | Buy |
332,207
+53,138
| +19% | +$434K | 0.03% | 553 |
|
|
2024
Q4 | $2.63M | Sell |
279,069
-537,938
| -66% | -$5.07M | 0.02% | 570 |
|
|
2024
Q3 | $8.73M | Buy |
817,007
+35,490
| +5% | +$379K | 0.05% | 226 |
|
|
2024
Q2 | $7.75M | Buy |
781,517
+138,132
| +21% | +$1.37M | 0.05% | 267 |
|
|
2024
Q1 | $7.58M | Buy |
643,385
+271,005
| +73% | +$3.19M | 0.06% | 221 |
|
|
2023
Q4 | $5.28M | Sell |
372,380
-569,053
| -60% | -$8.07M | 0.03% | 297 |
|
|
2023
Q3 | $11.4M | Buy |
941,433
+317,580
| +51% | +$3.86M | 0.11% | 173 |
|
|
2023
Q2 | $7.84M | Buy |
623,853
+468,018
| +300% | +$5.88M | 0.06% | 268 |
|
|
2023
Q1 | $1.73M | Buy |
155,835
+40,044
| +35% | +$444K | 0.01% | 852 |
|
|
2022
Q4 | $1.41M | Sell |
115,791
-177,189
| -60% | -$2.16M | 0.02% | 775 |
|
|
2022
Q3 | $3.06M | Buy |
292,980
+163,746
| +127% | +$1.71M | 0.04% | 554 |
|
|
2022
Q2 | $1.39M | Buy |
+129,234
| New | +$1.39M | 0.02% | 897 |
|
|
2022
Q1 | – | Sell |
-20,758
| Closed | -$240K | – | 2270 |
|
|
2021
Q4 | $240K | Sell |
20,758
-177,013
| -90% | -$2.05M | ﹤0.01% | 1705 |
|
|
2021
Q3 | $1.89M | Buy |
197,771
+109,376
| +124% | +$1.04M | 0.03% | 702 |
|
|
2021
Q2 | $852K | Sell |
88,395
-2,942
| -3% | -$28.4K | 0.01% | 1018 |
|
|
2021
Q1 | $902K | Buy |
91,337
+10,147
| +12% | +$100K | 0.01% | 938 |
|
|
2020
Q4 | $1.88M | Sell |
81,190
-25,326
| -24% | -$585K | 0.02% | 522 |
|
|
2020
Q3 | $1.5M | Buy |
+106,516
| New | +$1.5M | 0.03% | 459 |
|
|
2020
Q1 | – | Sell |
-46,457
| Closed | -$452K | – | 1211 |
|
|
2019
Q4 | $452K | Buy |
46,457
+23,757
| +105% | +$231K | 0.01% | 860 |
|
|
2019
Q3 | $182K | Buy |
+22,700
| New | +$182K | 0.01% | 1120 |
|